0.0621	2.7114	OMIM:101000	#101000 NEUROFIBROMATOSIS, TYPE II; NF2;;NEUROFIBROMATOSIS, CENTRAL TYPE;;ACOUSTIC SCHWANNOMAS, BILATERAL;;BILATERAL ACOUSTIC NEUROFIBROMATOSIS; BANF;;ACOUSTIC NEURINOMA, BILATERAL; ACN	NF2	4771
0.0621	1.8756	OMIM:117210	SPINOCEREBELLAR ATAXIA 31	BEAN1	146227
0.0621	1.8182	OMIM:614920	#614920 PEROXISOME BIOGENESIS DISORDER 14B; PEX14B	PEX11B	8799
0.0621	1.8032	OMIM:120040	COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS		
0.0621	1.6831	OMIM:614307	#614307 ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD;;AMACR DEFICIENCY	AMACR	23600
0.0621	1.5470	OMIM:212710	CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME		
0.0621	0.4562	OMIM:126180	DISCRIMINATION, TWO-POINT, REDUCTION IN		
0.0621	0.4562	OMIM:601696	NOVELTY SEEKING PERSONALITY TRAIT		
0.0621	0.4562	OMIM:309840	MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS		
0.0621	0.4562	OMIM:105570	ANDROSTENONE, ABILITY TO SMELL		
0.0621	0.4562	OMIM:244100	JUMPING FRENCHMAN OF MAINE		
0.0621	0.4562	OMIM:108390	ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY		
0.0621	0.4562	OMIM:155150	MEDIAN-ULNAR NERVE COMMUNICATIONS		
0.0621	0.4562	OMIM:158280	MOTION SICKNESS		
0.0621	0.4562	OMIM:270900	SPASTIC PSEUDOSCLEROSIS		
0.0621	0.4562	OMIM:100820	ACHOO SYNDROME		
0.0621	0.4562	OMIM:313000	SPATIAL VISUALIZATION, APTITUDE FOR		
0.0621	0.4562	OMIM:213500	CEREBRAL ANGIOPATHY, DYSPHORIC		
0.0621	0.4562	OMIM:300082	COGNITIVE FUNCTION 1, SOCIAL		
0.0621	0.4562	OMIM:156220	MERALGIA PARAESTHETICA, FAMILIAL		
